nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—CYP2C8—Mometasone—atopic dermatitis	0.118	0.158	CbGbCtD
Candesartan—PTGS1—Diphenhydramine—atopic dermatitis	0.117	0.157	CbGbCtD
Candesartan—CYP2C8—Loratadine—atopic dermatitis	0.0677	0.0908	CbGbCtD
Candesartan—ABCB1—Tacrolimus—atopic dermatitis	0.0626	0.0839	CbGbCtD
Candesartan—CYP2C9—Loratadine—atopic dermatitis	0.0472	0.0633	CbGbCtD
Candesartan—CYP2C9—Diphenhydramine—atopic dermatitis	0.0472	0.0633	CbGbCtD
Candesartan—ABCB1—Loratadine—atopic dermatitis	0.0458	0.0614	CbGbCtD
Candesartan—ABCB1—Methylprednisolone—atopic dermatitis	0.0419	0.0562	CbGbCtD
Candesartan—CYP2C8—Hydrocortisone—atopic dermatitis	0.0377	0.0505	CbGbCtD
Candesartan—ABCB1—Betamethasone—atopic dermatitis	0.0273	0.0365	CbGbCtD
Candesartan—ABCB1—Prednisolone—atopic dermatitis	0.0269	0.036	CbGbCtD
Candesartan—ABCB1—Hydrocortisone—atopic dermatitis	0.0255	0.0342	CbGbCtD
Candesartan—ABCB1—Prednisone—atopic dermatitis	0.0254	0.034	CbGbCtD
Candesartan—CYP2C8—Dexamethasone—atopic dermatitis	0.0234	0.0314	CbGbCtD
Candesartan—CYP2C9—Dexamethasone—atopic dermatitis	0.0163	0.0219	CbGbCtD
Candesartan—ABCB1—Dexamethasone—atopic dermatitis	0.0159	0.0213	CbGbCtD
Candesartan—Pranlukast—RNASE3—atopic dermatitis	0.00698	0.493	CrCbGaD
Candesartan—Pranlukast—IL5—atopic dermatitis	0.00622	0.439	CrCbGaD
Candesartan—AGTR1—ACE Inhibitor Pathway—CMA1—atopic dermatitis	0.00172	0.0976	CbGpPWpGaD
Candesartan—Pranlukast—TNF—atopic dermatitis	0.000964	0.0681	CrCbGaD
Candesartan—AGTR1—Allograft Rejection—FOXP3—atopic dermatitis	0.000465	0.0264	CbGpPWpGaD
Candesartan—AGTR1—Peptide GPCRs—CCR3—atopic dermatitis	0.000432	0.0245	CbGpPWpGaD
Candesartan—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.000404	0.00182	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL13—atopic dermatitis	0.000397	0.0226	CbGpPWpGaD
Candesartan—Hypotension—Tacrolimus—atopic dermatitis	0.000394	0.00177	CcSEcCtD
Candesartan—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000393	0.00177	CcSEcCtD
Candesartan—Vomiting—Loratadine—atopic dermatitis	0.000393	0.00177	CcSEcCtD
Candesartan—Rash—Loratadine—atopic dermatitis	0.000389	0.00175	CcSEcCtD
Candesartan—Dermatitis—Loratadine—atopic dermatitis	0.000389	0.00175	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.000387	0.022	CbGpPWpGaD
Candesartan—Headache—Loratadine—atopic dermatitis	0.000387	0.00174	CcSEcCtD
Candesartan—Sweating increased—Betamethasone—atopic dermatitis	0.000385	0.00173	CcSEcCtD
Candesartan—Sweating increased—Dexamethasone—atopic dermatitis	0.000385	0.00173	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000384	0.00173	CcSEcCtD
Candesartan—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.000383	0.00172	CcSEcCtD
Candesartan—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.000382	0.00172	CcSEcCtD
Candesartan—Haemoglobin—Prednisolone—atopic dermatitis	0.000381	0.00171	CcSEcCtD
Candesartan—Myocardial infarction—Triamcinolone—atopic dermatitis	0.000381	0.00171	CcSEcCtD
Candesartan—Asthenia—Mometasone—atopic dermatitis	0.00038	0.00171	CcSEcCtD
Candesartan—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.00038	0.00171	CcSEcCtD
Candesartan—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00038	0.00171	CcSEcCtD
Candesartan—Haemorrhage—Prednisolone—atopic dermatitis	0.000379	0.00171	CcSEcCtD
Candesartan—Paraesthesia—Tacrolimus—atopic dermatitis	0.000379	0.0017	CcSEcCtD
Candesartan—AGTR1—Peptide GPCRs—CXCR3—atopic dermatitis	0.000378	0.0214	CbGpPWpGaD
Candesartan—Dyspnoea—Tacrolimus—atopic dermatitis	0.000376	0.00169	CcSEcCtD
Candesartan—Somnolence—Tacrolimus—atopic dermatitis	0.000375	0.00169	CcSEcCtD
Candesartan—Pruritus—Mometasone—atopic dermatitis	0.000375	0.00169	CcSEcCtD
Candesartan—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000372	0.00167	CcSEcCtD
Candesartan—Dyspepsia—Tacrolimus—atopic dermatitis	0.000371	0.00167	CcSEcCtD
Candesartan—Haemorrhage—Hydrocortisone—atopic dermatitis	0.00037	0.00167	CcSEcCtD
Candesartan—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000367	0.00165	CcSEcCtD
Candesartan—Nausea—Loratadine—atopic dermatitis	0.000367	0.00165	CcSEcCtD
Candesartan—Epistaxis—Triamcinolone—atopic dermatitis	0.000366	0.00165	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL17A—atopic dermatitis	0.000366	0.0208	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000364	0.00164	CcSEcCtD
Candesartan—Fatigue—Tacrolimus—atopic dermatitis	0.000364	0.00164	CcSEcCtD
Candesartan—Diarrhoea—Mometasone—atopic dermatitis	0.000363	0.00163	CcSEcCtD
Candesartan—Hyperglycaemia—Dexamethasone—atopic dermatitis	0.000357	0.0016	CcSEcCtD
Candesartan—Hyperglycaemia—Betamethasone—atopic dermatitis	0.000357	0.0016	CcSEcCtD
Candesartan—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000353	0.00159	CcSEcCtD
Candesartan—Haemoglobin—Triamcinolone—atopic dermatitis	0.000351	0.00158	CcSEcCtD
Candesartan—Rash—Fluocinolone Acetonide—atopic dermatitis	0.00035	0.00157	CcSEcCtD
Candesartan—Haemoglobin—Methylprednisolone—atopic dermatitis	0.00035	0.00157	CcSEcCtD
Candesartan—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.00035	0.00157	CcSEcCtD
Candesartan—Rhinitis—Triamcinolone—atopic dermatitis	0.00035	0.00157	CcSEcCtD
Candesartan—Rhinitis—Methylprednisolone—atopic dermatitis	0.000349	0.00157	CcSEcCtD
Candesartan—Haemorrhage—Triamcinolone—atopic dermatitis	0.000349	0.00157	CcSEcCtD
Candesartan—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000348	0.00157	CcSEcCtD
Candesartan—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000348	0.00156	CcSEcCtD
Candesartan—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000348	0.00156	CcSEcCtD
Candesartan—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000348	0.00156	CcSEcCtD
Candesartan—Pharyngitis—Triamcinolone—atopic dermatitis	0.000346	0.00156	CcSEcCtD
Candesartan—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000346	0.00155	CcSEcCtD
Candesartan—Myocardial infarction—Betamethasone—atopic dermatitis	0.000346	0.00155	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.000345	0.0196	CbGpPWpGaD
Candesartan—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000345	0.00155	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL5—atopic dermatitis	0.00034	0.0193	CbGpPWpGaD
Candesartan—Vomiting—Mometasone—atopic dermatitis	0.000337	0.00152	CcSEcCtD
Candesartan—Sweating increased—Prednisone—atopic dermatitis	0.000335	0.00151	CcSEcCtD
Candesartan—Urticaria—Tacrolimus—atopic dermatitis	0.000335	0.00151	CcSEcCtD
Candesartan—Rash—Mometasone—atopic dermatitis	0.000334	0.0015	CcSEcCtD
Candesartan—Dermatitis—Mometasone—atopic dermatitis	0.000334	0.0015	CcSEcCtD
Candesartan—Abdominal pain—Tacrolimus—atopic dermatitis	0.000333	0.0015	CcSEcCtD
Candesartan—Body temperature increased—Tacrolimus—atopic dermatitis	0.000333	0.0015	CcSEcCtD
Candesartan—Headache—Mometasone—atopic dermatitis	0.000332	0.00149	CcSEcCtD
Candesartan—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00033	0.00148	CcSEcCtD
Candesartan—Mental disorder—Hydrocortisone—atopic dermatitis	0.000325	0.00146	CcSEcCtD
Candesartan—Malnutrition—Hydrocortisone—atopic dermatitis	0.000322	0.00145	CcSEcCtD
Candesartan—Neutropenia—Prednisone—atopic dermatitis	0.000322	0.00145	CcSEcCtD
Candesartan—Haemoglobin—Dexamethasone—atopic dermatitis	0.000318	0.00143	CcSEcCtD
Candesartan—Haemoglobin—Betamethasone—atopic dermatitis	0.000318	0.00143	CcSEcCtD
Candesartan—Haemorrhage—Dexamethasone—atopic dermatitis	0.000316	0.00142	CcSEcCtD
Candesartan—Haemorrhage—Betamethasone—atopic dermatitis	0.000316	0.00142	CcSEcCtD
Candesartan—Nausea—Mometasone—atopic dermatitis	0.000315	0.00142	CcSEcCtD
Candesartan—Hyperglycaemia—Prednisone—atopic dermatitis	0.000311	0.0014	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00031	0.0176	CbGpPWpGaD
Candesartan—Mental disorder—Methylprednisolone—atopic dermatitis	0.000305	0.00137	CcSEcCtD
Candesartan—Malnutrition—Methylprednisolone—atopic dermatitis	0.000303	0.00136	CcSEcCtD
Candesartan—Asthenia—Tacrolimus—atopic dermatitis	0.000303	0.00136	CcSEcCtD
Candesartan—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000303	0.00136	CcSEcCtD
Candesartan—Angioedema—Prednisolone—atopic dermatitis	0.000302	0.00136	CcSEcCtD
Candesartan—Myocardial infarction—Prednisone—atopic dermatitis	0.000301	0.00135	CcSEcCtD
Candesartan—Pruritus—Tacrolimus—atopic dermatitis	0.000298	0.00134	CcSEcCtD
Candesartan—Vertigo—Prednisolone—atopic dermatitis	0.000297	0.00133	CcSEcCtD
Candesartan—Angioedema—Hydrocortisone—atopic dermatitis	0.000295	0.00133	CcSEcCtD
Candesartan—Back pain—Triamcinolone—atopic dermatitis	0.000294	0.00132	CcSEcCtD
Candesartan—Vertigo—Hydrocortisone—atopic dermatitis	0.00029	0.0013	CcSEcCtD
Candesartan—Diarrhoea—Tacrolimus—atopic dermatitis	0.000289	0.0013	CcSEcCtD
Candesartan—Hypertension—Prednisolone—atopic dermatitis	0.000285	0.00128	CcSEcCtD
Candesartan—Dizziness—Tacrolimus—atopic dermatitis	0.000279	0.00125	CcSEcCtD
Candesartan—Hypertension—Hydrocortisone—atopic dermatitis	0.000278	0.00125	CcSEcCtD
Candesartan—Angioedema—Triamcinolone—atopic dermatitis	0.000277	0.00125	CcSEcCtD
Candesartan—Haemoglobin—Prednisone—atopic dermatitis	0.000277	0.00125	CcSEcCtD
Candesartan—Angioedema—Methylprednisolone—atopic dermatitis	0.000277	0.00125	CcSEcCtD
Candesartan—Haemorrhage—Prednisone—atopic dermatitis	0.000276	0.00124	CcSEcCtD
Candesartan—Myalgia—Hydrocortisone—atopic dermatitis	0.000275	0.00123	CcSEcCtD
Candesartan—Anxiety—Hydrocortisone—atopic dermatitis	0.000274	0.00123	CcSEcCtD
Candesartan—Vertigo—Triamcinolone—atopic dermatitis	0.000273	0.00123	CcSEcCtD
Candesartan—Vertigo—Methylprednisolone—atopic dermatitis	0.000272	0.00122	CcSEcCtD
Candesartan—Vomiting—Tacrolimus—atopic dermatitis	0.000268	0.00121	CcSEcCtD
Candesartan—Rash—Tacrolimus—atopic dermatitis	0.000266	0.0012	CcSEcCtD
Candesartan—Dermatitis—Tacrolimus—atopic dermatitis	0.000266	0.0012	CcSEcCtD
Candesartan—Cough—Triamcinolone—atopic dermatitis	0.000265	0.00119	CcSEcCtD
Candesartan—Headache—Tacrolimus—atopic dermatitis	0.000264	0.00119	CcSEcCtD
Candesartan—Tachycardia—Prednisolone—atopic dermatitis	0.000263	0.00118	CcSEcCtD
Candesartan—Hypertension—Triamcinolone—atopic dermatitis	0.000262	0.00118	CcSEcCtD
Candesartan—Hypertension—Methylprednisolone—atopic dermatitis	0.000262	0.00118	CcSEcCtD
Candesartan—Hyperhidrosis—Prednisolone—atopic dermatitis	0.00026	0.00117	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00026	0.0147	CbGpPWpGaD
Candesartan—Myalgia—Triamcinolone—atopic dermatitis	0.000258	0.00116	CcSEcCtD
Candesartan—Arthralgia—Methylprednisolone—atopic dermatitis	0.000258	0.00116	CcSEcCtD
Candesartan—Myalgia—Methylprednisolone—atopic dermatitis	0.000258	0.00116	CcSEcCtD
Candesartan—Anxiety—Methylprednisolone—atopic dermatitis	0.000257	0.00116	CcSEcCtD
Candesartan—Tachycardia—Hydrocortisone—atopic dermatitis	0.000257	0.00116	CcSEcCtD
Candesartan—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000254	0.00114	CcSEcCtD
Candesartan—Angioedema—Dexamethasone—atopic dermatitis	0.000252	0.00113	CcSEcCtD
Candesartan—Angioedema—Betamethasone—atopic dermatitis	0.000252	0.00113	CcSEcCtD
Candesartan—Nausea—Tacrolimus—atopic dermatitis	0.000251	0.00113	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.000249	0.0142	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL10—atopic dermatitis	0.000249	0.0141	CbGpPWpGaD
Candesartan—Vertigo—Betamethasone—atopic dermatitis	0.000248	0.00111	CcSEcCtD
Candesartan—Vertigo—Dexamethasone—atopic dermatitis	0.000248	0.00111	CcSEcCtD
Candesartan—Hypotension—Hydrocortisone—atopic dermatitis	0.000246	0.00111	CcSEcCtD
Candesartan—Paraesthesia—Prednisolone—atopic dermatitis	0.000242	0.00109	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL4—atopic dermatitis	0.000242	0.0137	CbGpPWpGaD
Candesartan—Tachycardia—Triamcinolone—atopic dermatitis	0.000242	0.00109	CcSEcCtD
Candesartan—Mental disorder—Prednisone—atopic dermatitis	0.000241	0.00109	CcSEcCtD
Candesartan—Tachycardia—Methylprednisolone—atopic dermatitis	0.000241	0.00109	CcSEcCtD
Candesartan—Malnutrition—Prednisone—atopic dermatitis	0.00024	0.00108	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.00024	0.00108	CcSEcCtD
Candesartan—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.00024	0.00108	CcSEcCtD
Candesartan—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000239	0.00108	CcSEcCtD
Candesartan—Hypertension—Betamethasone—atopic dermatitis	0.000238	0.00107	CcSEcCtD
Candesartan—Hypertension—Dexamethasone—atopic dermatitis	0.000238	0.00107	CcSEcCtD
Candesartan—AGTR1—Peptide GPCRs—CCR5—atopic dermatitis	0.000237	0.0134	CbGpPWpGaD
Candesartan—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000236	0.00106	CcSEcCtD
Candesartan—Myalgia—Betamethasone—atopic dermatitis	0.000235	0.00106	CcSEcCtD
Candesartan—Myalgia—Dexamethasone—atopic dermatitis	0.000235	0.00106	CcSEcCtD
Candesartan—Anxiety—Dexamethasone—atopic dermatitis	0.000234	0.00105	CcSEcCtD
Candesartan—Anxiety—Betamethasone—atopic dermatitis	0.000234	0.00105	CcSEcCtD
Candesartan—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000232	0.00104	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000231	0.0131	CbGpPWpGaD
Candesartan—Hypotension—Methylprednisolone—atopic dermatitis	0.000231	0.00104	CcSEcCtD
Candesartan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000227	0.00102	CcSEcCtD
Candesartan—Fatigue—Hydrocortisone—atopic dermatitis	0.000227	0.00102	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000226	0.00102	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000225	0.00101	CcSEcCtD
Candesartan—Paraesthesia—Triamcinolone—atopic dermatitis	0.000222	0.001	CcSEcCtD
Candesartan—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000222	0.000999	CcSEcCtD
Candesartan—Anaemia—Prednisone—atopic dermatitis	0.000222	0.000998	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—CXCL8—atopic dermatitis	0.000222	0.0126	CbGpPWpGaD
Candesartan—Dyspnoea—Triamcinolone—atopic dermatitis	0.000221	0.000994	CcSEcCtD
Candesartan—Thrombocytopenia—Betamethasone—atopic dermatitis	0.00022	0.00099	CcSEcCtD
Candesartan—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.00022	0.00099	CcSEcCtD
Candesartan—Tachycardia—Betamethasone—atopic dermatitis	0.000219	0.000987	CcSEcCtD
Candesartan—Tachycardia—Dexamethasone—atopic dermatitis	0.000219	0.000987	CcSEcCtD
Candesartan—Angioedema—Prednisone—atopic dermatitis	0.000219	0.000986	CcSEcCtD
Candesartan—Dyspepsia—Triamcinolone—atopic dermatitis	0.000218	0.000981	CcSEcCtD
Candesartan—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000218	0.000979	CcSEcCtD
Candesartan—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000217	0.000978	CcSEcCtD
Candesartan—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000217	0.000978	CcSEcCtD
Candesartan—Vertigo—Prednisone—atopic dermatitis	0.000216	0.00097	CcSEcCtD
Candesartan—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000215	0.000968	CcSEcCtD
Candesartan—Urticaria—Prednisolone—atopic dermatitis	0.000214	0.000963	CcSEcCtD
Candesartan—Fatigue—Triamcinolone—atopic dermatitis	0.000214	0.000961	CcSEcCtD
Candesartan—Fatigue—Methylprednisolone—atopic dermatitis	0.000213	0.000959	CcSEcCtD
Candesartan—Hypotension—Betamethasone—atopic dermatitis	0.00021	0.000945	CcSEcCtD
Candesartan—Hypotension—Dexamethasone—atopic dermatitis	0.00021	0.000945	CcSEcCtD
Candesartan—Urticaria—Hydrocortisone—atopic dermatitis	0.000209	0.000941	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.000209	0.0118	CbGpPWpGaD
Candesartan—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000208	0.000936	CcSEcCtD
Candesartan—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000208	0.000936	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000208	0.0118	CbGpPWpGaD
Candesartan—Hypertension—Prednisone—atopic dermatitis	0.000207	0.000932	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000205	0.000922	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000205	0.000922	CcSEcCtD
Candesartan—Arthralgia—Prednisone—atopic dermatitis	0.000204	0.000919	CcSEcCtD
Candesartan—Myalgia—Prednisone—atopic dermatitis	0.000204	0.000919	CcSEcCtD
Candesartan—Anxiety—Prednisone—atopic dermatitis	0.000204	0.000916	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000203	0.0115	CbGpPWpGaD
Candesartan—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000202	0.00091	CcSEcCtD
Candesartan—Paraesthesia—Betamethasone—atopic dermatitis	0.000202	0.000908	CcSEcCtD
Candesartan—Paraesthesia—Dexamethasone—atopic dermatitis	0.000202	0.000908	CcSEcCtD
Candesartan—Dyspepsia—Dexamethasone—atopic dermatitis	0.000198	0.00089	CcSEcCtD
Candesartan—Dyspepsia—Betamethasone—atopic dermatitis	0.000198	0.00089	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—CCL22—atopic dermatitis	0.000198	0.0112	CbGpPWpGaD
Candesartan—Urticaria—Triamcinolone—atopic dermatitis	0.000197	0.000886	CcSEcCtD
Candesartan—Urticaria—Methylprednisolone—atopic dermatitis	0.000196	0.000884	CcSEcCtD
Candesartan—Body temperature increased—Triamcinolone—atopic dermatitis	0.000196	0.000881	CcSEcCtD
Candesartan—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000195	0.000879	CcSEcCtD
Candesartan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000194	0.000873	CcSEcCtD
Candesartan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000194	0.000873	CcSEcCtD
Candesartan—Fatigue—Dexamethasone—atopic dermatitis	0.000194	0.000872	CcSEcCtD
Candesartan—Fatigue—Betamethasone—atopic dermatitis	0.000194	0.000872	CcSEcCtD
Candesartan—Tachycardia—Prednisone—atopic dermatitis	0.000191	0.00086	CcSEcCtD
Candesartan—Hyperhidrosis—Prednisone—atopic dermatitis	0.000189	0.000852	CcSEcCtD
Candesartan—Asthenia—Hydrocortisone—atopic dermatitis	0.000189	0.000849	CcSEcCtD
Candesartan—Pruritus—Hydrocortisone—atopic dermatitis	0.000186	0.000838	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.000186	0.0106	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000185	0.0105	CbGpPWpGaD
Candesartan—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000184	0.000827	CcSEcCtD
Candesartan—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000184	0.000827	CcSEcCtD
Candesartan—AGTR1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000184	0.0104	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—NPS—atopic dermatitis	0.000184	0.0104	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000181	0.0103	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000181	0.0103	CbGpPWpGaD
Candesartan—Diarrhoea—Hydrocortisone—atopic dermatitis	0.00018	0.00081	CcSEcCtD
Candesartan—Urticaria—Dexamethasone—atopic dermatitis	0.000179	0.000804	CcSEcCtD
Candesartan—Urticaria—Betamethasone—atopic dermatitis	0.000179	0.000804	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000178	0.000803	CcSEcCtD
Candesartan—Dizziness—Prednisolone—atopic dermatitis	0.000178	0.000802	CcSEcCtD
Candesartan—Asthenia—Triamcinolone—atopic dermatitis	0.000178	0.0008	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000178	0.0101	CbGpPWpGaD
Candesartan—Abdominal pain—Dexamethasone—atopic dermatitis	0.000178	0.0008	CcSEcCtD
Candesartan—Abdominal pain—Betamethasone—atopic dermatitis	0.000178	0.0008	CcSEcCtD
Candesartan—Body temperature increased—Betamethasone—atopic dermatitis	0.000178	0.0008	CcSEcCtD
Candesartan—Body temperature increased—Dexamethasone—atopic dermatitis	0.000178	0.0008	CcSEcCtD
Candesartan—Asthenia—Methylprednisolone—atopic dermatitis	0.000177	0.000798	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—CCL27—atopic dermatitis	0.000176	0.01	CbGpPWpGaD
Candesartan—Paraesthesia—Prednisone—atopic dermatitis	0.000176	0.000791	CcSEcCtD
Candesartan—Pruritus—Triamcinolone—atopic dermatitis	0.000175	0.000789	CcSEcCtD
Candesartan—Pruritus—Methylprednisolone—atopic dermatitis	0.000175	0.000787	CcSEcCtD
Candesartan—Dizziness—Hydrocortisone—atopic dermatitis	0.000174	0.000783	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK8—atopic dermatitis	0.000172	0.00978	CbGpPWpGaD
Candesartan—Dyspepsia—Prednisone—atopic dermatitis	0.000172	0.000775	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—CASP8—atopic dermatitis	0.000172	0.00976	CbGpPWpGaD
Candesartan—Rash—Prednisolone—atopic dermatitis	0.00017	0.000764	CcSEcCtD
Candesartan—Dermatitis—Prednisolone—atopic dermatitis	0.00017	0.000764	CcSEcCtD
Candesartan—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000169	0.000761	CcSEcCtD
Candesartan—Fatigue—Prednisone—atopic dermatitis	0.000169	0.000759	CcSEcCtD
Candesartan—Headache—Prednisolone—atopic dermatitis	0.000169	0.000759	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000167	0.00949	CbGpPWpGaD
Candesartan—Vomiting—Hydrocortisone—atopic dermatitis	0.000167	0.000753	CcSEcCtD
Candesartan—Rash—Hydrocortisone—atopic dermatitis	0.000166	0.000746	CcSEcCtD
Candesartan—Dermatitis—Hydrocortisone—atopic dermatitis	0.000166	0.000746	CcSEcCtD
Candesartan—Headache—Hydrocortisone—atopic dermatitis	0.000165	0.000742	CcSEcCtD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000164	0.00932	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000164	0.00932	CbGpPWpGaD
Candesartan—Dizziness—Triamcinolone—atopic dermatitis	0.000164	0.000737	CcSEcCtD
Candesartan—Dizziness—Methylprednisolone—atopic dermatitis	0.000163	0.000736	CcSEcCtD
Candesartan—Asthenia—Dexamethasone—atopic dermatitis	0.000161	0.000726	CcSEcCtD
Candesartan—Asthenia—Betamethasone—atopic dermatitis	0.000161	0.000726	CcSEcCtD
Candesartan—Gastrointestinal pain—Prednisone—atopic dermatitis	0.00016	0.00072	CcSEcCtD
Candesartan—Nausea—Prednisolone—atopic dermatitis	0.00016	0.00072	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000159	0.00903	CbGpPWpGaD
Candesartan—Pruritus—Dexamethasone—atopic dermatitis	0.000159	0.000716	CcSEcCtD
Candesartan—Pruritus—Betamethasone—atopic dermatitis	0.000159	0.000716	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—CCL17—atopic dermatitis	0.000158	0.00897	CbGpPWpGaD
Candesartan—Vomiting—Triamcinolone—atopic dermatitis	0.000158	0.000709	CcSEcCtD
Candesartan—Vomiting—Methylprednisolone—atopic dermatitis	0.000157	0.000707	CcSEcCtD
Candesartan—Nausea—Hydrocortisone—atopic dermatitis	0.000156	0.000703	CcSEcCtD
Candesartan—Rash—Triamcinolone—atopic dermatitis	0.000156	0.000703	CcSEcCtD
Candesartan—Dermatitis—Triamcinolone—atopic dermatitis	0.000156	0.000702	CcSEcCtD
Candesartan—Rash—Methylprednisolone—atopic dermatitis	0.000156	0.000701	CcSEcCtD
Candesartan—Dermatitis—Methylprednisolone—atopic dermatitis	0.000156	0.000701	CcSEcCtD
Candesartan—Urticaria—Prednisone—atopic dermatitis	0.000156	0.0007	CcSEcCtD
Candesartan—Headache—Triamcinolone—atopic dermatitis	0.000155	0.000698	CcSEcCtD
Candesartan—Headache—Methylprednisolone—atopic dermatitis	0.000155	0.000697	CcSEcCtD
Candesartan—Abdominal pain—Prednisone—atopic dermatitis	0.000155	0.000696	CcSEcCtD
Candesartan—Body temperature increased—Prednisone—atopic dermatitis	0.000155	0.000696	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—TNF—atopic dermatitis	0.000154	0.00876	CbGpPWpGaD
Candesartan—Diarrhoea—Betamethasone—atopic dermatitis	0.000154	0.000692	CcSEcCtD
Candesartan—Diarrhoea—Dexamethasone—atopic dermatitis	0.000154	0.000692	CcSEcCtD
Candesartan—Dizziness—Dexamethasone—atopic dermatitis	0.000149	0.000669	CcSEcCtD
Candesartan—Dizziness—Betamethasone—atopic dermatitis	0.000149	0.000669	CcSEcCtD
Candesartan—Nausea—Triamcinolone—atopic dermatitis	0.000147	0.000662	CcSEcCtD
Candesartan—Nausea—Methylprednisolone—atopic dermatitis	0.000147	0.000661	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IFNG—atopic dermatitis	0.000146	0.0083	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000144	0.00815	CbGpPWpGaD
Candesartan—Vomiting—Betamethasone—atopic dermatitis	0.000143	0.000643	CcSEcCtD
Candesartan—Vomiting—Dexamethasone—atopic dermatitis	0.000143	0.000643	CcSEcCtD
Candesartan—Rash—Dexamethasone—atopic dermatitis	0.000142	0.000638	CcSEcCtD
Candesartan—Rash—Betamethasone—atopic dermatitis	0.000142	0.000638	CcSEcCtD
Candesartan—Dermatitis—Dexamethasone—atopic dermatitis	0.000142	0.000637	CcSEcCtD
Candesartan—Dermatitis—Betamethasone—atopic dermatitis	0.000142	0.000637	CcSEcCtD
Candesartan—Headache—Betamethasone—atopic dermatitis	0.000141	0.000634	CcSEcCtD
Candesartan—Headache—Dexamethasone—atopic dermatitis	0.000141	0.000634	CcSEcCtD
Candesartan—Asthenia—Prednisone—atopic dermatitis	0.00014	0.000632	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000139	0.0079	CbGpPWpGaD
Candesartan—Pruritus—Prednisone—atopic dermatitis	0.000139	0.000623	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—atopic dermatitis	0.000136	0.00774	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000136	0.00774	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000136	0.00774	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—CXCL8—atopic dermatitis	0.000136	0.00771	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	0.000135	0.00766	CbGpPWpGaD
Candesartan—Diarrhoea—Prednisone—atopic dermatitis	0.000134	0.000603	CcSEcCtD
Candesartan—Nausea—Betamethasone—atopic dermatitis	0.000134	0.000601	CcSEcCtD
Candesartan—Nausea—Dexamethasone—atopic dermatitis	0.000134	0.000601	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL1B—atopic dermatitis	0.00013	0.0074	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL2—atopic dermatitis	0.00013	0.00737	CbGpPWpGaD
Candesartan—Dizziness—Prednisone—atopic dermatitis	0.000129	0.000583	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—CCL11—atopic dermatitis	0.000127	0.00723	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—IL6—atopic dermatitis	0.000125	0.00707	CbGpPWpGaD
Candesartan—Vomiting—Prednisone—atopic dermatitis	0.000124	0.00056	CcSEcCtD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000124	0.00705	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000124	0.00702	CbGpPWpGaD
Candesartan—Rash—Prednisone—atopic dermatitis	0.000123	0.000555	CcSEcCtD
Candesartan—Dermatitis—Prednisone—atopic dermatitis	0.000123	0.000555	CcSEcCtD
Candesartan—Headache—Prednisone—atopic dermatitis	0.000123	0.000552	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000122	0.0069	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000122	0.0069	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000119	0.00677	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL13—atopic dermatitis	0.000117	0.00662	CbGpPWpGaD
Candesartan—Nausea—Prednisone—atopic dermatitis	0.000116	0.000523	CcSEcCtD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000116	0.00658	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000111	0.00632	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	0.000107	0.00609	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCR3—atopic dermatitis	0.000104	0.00589	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL22—atopic dermatitis	0.000101	0.00576	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL5—atopic dermatitis	9.98e-05	0.00566	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCL27—atopic dermatitis	9.96e-05	0.00565	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	9.64e-05	0.00547	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—TNF—atopic dermatitis	9.46e-05	0.00537	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—TAC1—atopic dermatitis	9.26e-05	0.00525	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—NPS—atopic dermatitis	9.26e-05	0.00525	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCR3—atopic dermatitis	9.08e-05	0.00515	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL27—atopic dermatitis	9.05e-05	0.00513	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	8.72e-05	0.00495	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	8.3e-05	0.00471	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL17—atopic dermatitis	8.11e-05	0.0046	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	7.47e-05	0.00424	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL10—atopic dermatitis	7.34e-05	0.00416	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL10—atopic dermatitis	7.3e-05	0.00414	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	7.14e-05	0.00405	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL4—atopic dermatitis	7.1e-05	0.00403	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IFNG—atopic dermatitis	7e-05	0.00397	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	6.97e-05	0.00396	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	6.74e-05	0.00382	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL11—atopic dermatitis	6.54e-05	0.00371	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FCER2—atopic dermatitis	6.45e-05	0.00366	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCL5—atopic dermatitis	6.32e-05	0.00358	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL1B—atopic dermatitis	6.24e-05	0.00354	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL22—atopic dermatitis	6e-05	0.0034	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCR3—atopic dermatitis	5.87e-05	0.00333	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCR5—atopic dermatitis	5.69e-05	0.00323	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GLB1—atopic dermatitis	5.65e-05	0.0032	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ADSL—atopic dermatitis	5.41e-05	0.00307	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL27—atopic dermatitis	5.34e-05	0.00303	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCR3—atopic dermatitis	5.33e-05	0.00302	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—NPS—atopic dermatitis	5.23e-05	0.00297	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—TAC1—atopic dermatitis	5.23e-05	0.00297	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCR3—atopic dermatitis	5.13e-05	0.00291	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	5.05e-05	0.00286	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL5—atopic dermatitis	4.86e-05	0.00276	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL17—atopic dermatitis	4.79e-05	0.00272	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—NPS—atopic dermatitis	4.75e-05	0.0027	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—TAC1—atopic dermatitis	4.75e-05	0.0027	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCR3—atopic dermatitis	4.66e-05	0.00264	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.61e-05	0.00262	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—atopic dermatitis	4.53e-05	0.00257	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.52e-05	0.00256	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL5—atopic dermatitis	4.42e-05	0.00251	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	4.29e-05	0.00243	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KIF3A—atopic dermatitis	4.27e-05	0.00242	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL10—atopic dermatitis	4.15e-05	0.00235	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	3.99e-05	0.00226	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CMA1—atopic dermatitis	3.86e-05	0.00219	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL11—atopic dermatitis	3.86e-05	0.00219	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	3.83e-05	0.00217	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL2—atopic dermatitis	3.81e-05	0.00216	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	3.77e-05	0.00214	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL10—atopic dermatitis	3.77e-05	0.00214	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.75e-05	0.00213	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	3.65e-05	0.00207	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT6—atopic dermatitis	3.63e-05	0.00206	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCL5—atopic dermatitis	3.57e-05	0.00203	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL8—atopic dermatitis	3.44e-05	0.00195	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.43e-05	0.00195	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL5—atopic dermatitis	3.24e-05	0.00184	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCR5—atopic dermatitis	3.22e-05	0.00183	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GLB1—atopic dermatitis	3.18e-05	0.0018	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCR3—atopic dermatitis	3.15e-05	0.00179	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ADSL—atopic dermatitis	3.05e-05	0.00173	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCR5—atopic dermatitis	2.92e-05	0.00166	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TAC1—atopic dermatitis	2.81e-05	0.00159	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NPS—atopic dermatitis	2.81e-05	0.00159	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—atopic dermatitis	2.78e-05	0.00158	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.76e-05	0.00157	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCR3—atopic dermatitis	2.75e-05	0.00156	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL5—atopic dermatitis	2.61e-05	0.00148	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.56e-05	0.00145	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.49e-05	0.00141	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.32e-05	0.00131	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL10—atopic dermatitis	2.23e-05	0.00126	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GLB1—atopic dermatitis	2.05e-05	0.00117	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ADSL—atopic dermatitis	1.97e-05	0.00112	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.94e-05	0.0011	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL5—atopic dermatitis	1.92e-05	0.00109	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—atopic dermatitis	1.86e-05	0.00105	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARA—atopic dermatitis	1.83e-05	0.00104	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GLB1—atopic dermatitis	1.79e-05	0.00102	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NGF—atopic dermatitis	1.77e-05	0.00101	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL8—atopic dermatitis	1.77e-05	0.001	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.73e-05	0.000983	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCR5—atopic dermatitis	1.73e-05	0.000979	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ADSL—atopic dermatitis	1.72e-05	0.000973	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—atopic dermatitis	1.69e-05	0.000958	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GLB1—atopic dermatitis	1.67e-05	0.000948	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ADSL—atopic dermatitis	1.6e-05	0.000909	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.5e-05	0.000849	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NFKBIA—atopic dermatitis	1.46e-05	0.00083	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.37e-05	0.000778	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.24e-05	0.000703	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.22e-05	0.000691	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL8—atopic dermatitis	1.04e-05	0.000592	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARA—atopic dermatitis	1.03e-05	0.000585	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—atopic dermatitis	9.97e-06	0.000566	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—atopic dermatitis	9.92e-06	0.000563	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK8—atopic dermatitis	9.18e-06	0.000521	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARA—atopic dermatitis	6.67e-06	0.000378	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—atopic dermatitis	5.86e-06	0.000332	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARA—atopic dermatitis	5.81e-06	0.000329	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARA—atopic dermatitis	5.42e-06	0.000308	CbGpPWpGaD
